Simple Science

Cutting edge science explained simply

# Health Sciences# Primary Care Research

Understanding Shared Medical Appointments for Chronic Conditions

An overview of Shared Medical Appointments and their impact on patient care.

― 5 min read


SMAs: New Approach toSMAs: New Approach toCareAppointments on patient care.Analyzing the impact of Shared Medical
Table of Contents

Shared Medical Appointments (SMAs) are a form of healthcare where patients with similar long-term health issues meet with their doctor together in a group setting. These appointments usually last between 60 to 120 minutes and can involve not just doctors, but also other health professionals like nurses, pharmacists, and psychologists. The aim of SMAs is to improve the care of patients who often have multiple long-term conditions.

How SMAs Work

In a typical SMA, a group of about 6 to 15 patients with similar health conditions gathers. They have time to ask questions and receive education about their health during the session. While SMAs maintain some aspects of regular doctor visits-like check-ups and personalized reviews of medical records-the group setting allows patients to learn from each other and share experiences. They have been used for various health issues, including diabetes, high blood pressure, and chronic pain.

Benefits of SMAs

Research shows that both patients and doctors often view SMAs positively. Patients report feeling more confident in managing their health, while Healthcare Providers see SMAs as a more efficient way to deliver care. However, past studies have shown mixed results when it comes to measuring the effectiveness of SMAs. Some patients in the SMA groups experienced improvements in certain health markers, such as blood sugar levels and blood pressure, compared to those receiving typical one-on-one care.

Research on SMAs

A major review focused on the effects of SMAs on patients with long-term health conditions, specifically looking at Health Outcomes and the use of healthcare services. The main questions addressed were whether SMAs lead to better health outcomes for patients and if they reduce the number of healthcare services used.

Study Parameters

The review included various studies, gathering data from trials conducted between 2013 and 2020. Researchers ensured that these studies met certain criteria, specifically focusing on SMAs where each patient still received some one-on-one time with the doctor.

Gathering Evidence

To find relevant trials, researchers used a wide-reaching search strategy. They looked for studies in medical databases, gathering data both from newer studies and from older ones by examining references in previous research. Each eligible trial was carefully screened and analyzed for quality and relevance.

Understanding the Results

The studies examined included a variety of patients, often with diabetes being the most common long-term condition. Many of the research trials took place in the United States, with some conducted in other countries.

Key Findings

When looking at health indicators like blood sugar levels and blood pressure, some improvements were noted in patients attending SMAs compared to traditional care. However, there were no significant differences in hospital visits or emergency department use between those in SMAs and those in standard care.

Psychological and Quality Of Life Measures

The review also considered how SMAs affected patients' quality of life and feelings of satisfaction about their healthcare. Some studies found that patients in SMA settings reported a better quality of life than those receiving usual care. Yet, the findings on self-efficacy-the confidence in managing one’s health-were mixed, with no clear advantages for SMA participants.

Cost and Resource Use

Cost analysis surrounding SMAs was limited but varied. Some trials suggested that SMAs might be more expensive to run, while others showed savings compared to regular care. The inconsistency in these findings makes it hard to draw firm conclusions about the financial implications of SMAs.

Limitations of the Current Evidence

While this review provides valuable insights, it does have limitations. One major challenge is that many studies did not report enough details about how SMAs were conducted. This lack of information can make it difficult to understand what aspects of SMAs contribute to their effectiveness.

Additionally, most studies assessed patients with chronic conditions like diabetes. The results may not apply to patients with other conditions. There is also a concern that the studies often did not include sufficient blinding, which could affect the outcomes.

Future Research Directions

To improve the understanding of SMAs, future research should aim to unify outcome measures across studies. This means that all trials should report on the same types of outcomes, such as physical activity and patient satisfaction, to make comparisons easier. Establishing a standard set of outcomes for SMAs could facilitate more reliable evaluations.

Moreover, examining the role of various healthcare professionals involved in SMAs may provide insights into what makes these appointments successful. Understanding how SMAs can integrate into standard healthcare practices is also essential, especially since some reports suggest that they are used alongside regular one-on-one appointments rather than replacing them.

Conclusion

Shared Medical Appointments present a unique way of delivering healthcare for individuals with long-term conditions. While they do offer some benefits, particularly in terms of patient confidence and group learning, more research is needed to fully understand their effectiveness and potential impact on healthcare services. Ensuring that future studies are well-designed and provide thorough details will contribute to better outcomes for patients and a clearer picture of how SMAs fit within the healthcare system.

Original Source

Title: Effectiveness of shared medical appointments delivered in primary care for improving health outcomes in patients with long-term conditions: a systematic review of randomised controlled trials

Abstract: ObjectivesShared medical appointments (SMAs) have the potential to address interlinked challenges of limited capacity in primary healthcare and rising prevalence of patients with multiple long-term conditions (LTCs). This review aimed to examine the effectiveness of SMAs compared to one-to-one appointments in primary care at improving health outcomes and reducing demand on healthcare services. MethodsWe searched for randomised controlled trials (RCTs) of SMAs involving patients with LTCs in primary care across six databases from 2013-2020 and added eligible papers identified from previous relevant reviews. Data were extracted and outcomes narratively synthesised, meta-analysis was undertaken where possible. ResultsTwenty-three unique trials were included. SMA models varied in terms of components, mode of delivery and target population. Most trials recruited patients with a single LTC, most commonly diabetes (n=12), although eight trials selected patients with multiple LTCs. There was substantial heterogeneity in outcome measures which we categorised into health outcomes (biomedical indicators, psychological and well-being measures), healthcare utilisation, and cost and resource use. Meta-analysis showed that participants in SMA groups had lower diastolic blood pressure than those in usual care (d=-0.123, 95%CI = - 0.22, -0.03, n=8). No statistically significant differences were found across other outcomes. Compared with usual care, SMAs had no significant effect on healthcare service use. ConclusionsSMAs were at least as effective as usual care in terms of health outcomes and did not lead to increased healthcare service use in the short-term. To strengthen the evidence base, future studies should target standardised behavioural and health outcomes and clearly report SMA components so key behavioural ingredients can be identified. Similarly, transparent approaches to measuring costs would improve comparability between studies. To better understand SMAs potential to reduce demand on healthcare services, further investigation is needed as to how SMAs can be best incorporated in the patient care pathway. PROSPERO protocol registrationCRD42020173084 299/300 STRENGTHS AND LIMITATIONSO_LIFocus on randomised controlled trials, highest quality evidence of the effectiveness of SMAs in primary care for long term conditions C_LIO_LIRobust search strategy, based on previous high-quality review; refined by information specialists to focus on primary care C_LIO_LIRapidly evolving area of practice and publications and the most recent evidence may be missing. C_LIO_LISmall number of studies reported resource use and costs limiting conclusions regarding efficacy of SMAs in primary care. C_LI FUNDINGThis paper is independent research commissioned and funded by the NIHR PRU in Behavioural Science (Award: PR-PRU-1217-20501). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health and Social Care or its arms length bodies, and other Government Departments. The funders had no role in the design of the study, collection, analysis or interpretation of data or in the writing of the manuscript. COMPETING INTERESTSNone to declare. CHECKLISTSee supplementary material for PRISMA checklist.

Authors: Fiona E Graham, M. Y. Tang, A. O'Donnell, F. Beyer, C. Richmond, F. F. Sniehotta, E. F. S. Kaner

Last Update: 2023-09-01 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2022.03.24.22272866

Source PDF: https://www.medrxiv.org/content/10.1101/2022.03.24.22272866.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

More from authors

Similar Articles